Edge-GPU Breast Tomosynthesis Box Market Report 2026

Edge-GPU Breast Tomosynthesis Box Market Overview

• Edge-GPU Breast Tomosynthesis Box market size has reached to $0.53 billion in 2025 • Expected to grow to $0.99 billion in 2030 at a compound annual growth rate (CAGR) of 13% • Growth Driver: Surge In Breast Cancer Driving Growth Due To Increasing Need For Early And Accurate Detection • Market Trend: Innovation In Edge-GPU Breast Tomosynthesis Boxes Through Accelerated Image Processing For Enhanced Clarity, Reduced Scan Time • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Edge-GPU Breast Tomosynthesis Box Market?

The edge-GPU breast tomosynthesis box refers to an advanced imaging solution that integrates high-performance edge computing with breast tomosynthesis technology. It enables rapid, high-resolution 3D breast imaging by processing large volumes of data directly at the edge, reducing latency and reliance on centralized servers. This system typically combines GPU-powered workstations, specialized detectors, and imaging software to enhance diagnostic accuracy. It is widely used in healthcare settings for early detection and precise assessment of breast abnormalities, improving workflow efficiency and patient outcomes. The main product types of edge-GPU breast tomosynthesis box are standalone edge-GPU box, integrated edge- GPU systems. A standalone edge graphics processing unit box is an independent computing device designed to perform high-performance data processing at the edge of a network. These are distributed through various distribution channels such as direct sales, distributors, online sales, others. These are used in various applications such as breast cancer screening, diagnostic imaging, research and development, others and also by various end-users such as hospitals, diagnostic centers, research institutes.

What Is The Edge-GPU Breast Tomosynthesis Box Market Growth Forecast?

The edge-gpu breast tomosynthesis box market size is expected to see rapid growth in the next few years. It will grow to $0.99 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to AI-driven diagnostic tools, expansion of portable screening units, integration with cloud imaging platforms, faster image processing capabilities, increased adoption in research and clinical settings. Major trends in the forecast period include real-time 3D imaging, gpu-accelerated processing, enhanced diagnostic accuracy, ai-based image analysis, portable imaging solutions.

Global Edge-GPU Breast Tomosynthesis Box Market Segmentation

1) By Product Type: Standalone Edge-GPU Box, Integrated Edge-GPU Systems 2) By Distribution Channel: Direct Sales, Distributors, Other Distribution Types 3) By Application Type: Breast Cancer Screening, Diagnostic Imaging 4) By End-User: Hospitals, Diagnostic Centers Subsegments: 1) By Standalone Edge-GPU Box: Compact Edge-GPU Box, High-Performance Edge-GPU Box, Modular Edge-GPU Box 2) By Integrated Edge-GPU Systems: Hospital Integrated Systems, Diagnostic Center Integrated Systems

What Is The Driver Of The Edge-GPU Breast Tomosynthesis Box Market?

The rising prevalence of breast cancer is expected to propel the growth of the edge-GPU breast tomosynthesis box market going forward. Breast cancer refers to a disease in which abnormal cells in the breast grow uncontrollably, forming a malignant tumor, and may spread to other parts of the body, with early detection through screening and awareness significantly improving treatment outcomes and survival rates. Rising prevalence of breast cancer is largely due to lifestyle changes, as factors such as poor diet, reduced physical activity, and hormonal influences increase the risk of abnormal cell growth in breast tissue, resulting to more cases being diagnosed globally over time. The edge-GPU breast tomosynthesis box helps in breast cancer by providing high-resolution 3D imaging that enables early and accurate detection of tumors, improves diagnostic precision, and supports faster, more efficient image processing for better treatment planning. For instance, in July 2024, according to the American Cancer Society (ACS), a U.S.-based nonprofit organization dedicated to cancer research, education, and patient support, in 2024, an estimated 310,720 new cases of invasive breast cancer will be diagnosed among U.S. women, with 16% occurring in those under 50, and an additional 56,500 cases of DCIS (stage 0) expected. Therefore, the rising prevalence of breast cancer is driving the growth of the edge-GPU breast tomosynthesis box industry.

Key Players In The Global Edge-GPU Breast Tomosynthesis Box Market

Major companies operating in the edge-gpu breast tomosynthesis box market are Hologic Inc., GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers, Canon Medical Systems Corporation, Planmed Oy, Metaltronica S.p.A., General Medical Merate (IMS GIOTTO), Villa Sistemi Medicali, DMS Imaging, DRTECH Corporation, Stephanix, Delphinus Medical Technologies, Konica Minolta, Carestream Health, Agfa-Gevaert N.V., IDETEC Medical Imaging, Xenox (Xenox Medical), Aurora Imaging Technology, Micrima Ltd., Neusoft Medical Systems, Landwind Medical

Global Edge-GPU Breast Tomosynthesis Box Market Trends and Insights

Major companies operating in the Edge-GPU breast tomosynthesis box are focusing on technological innovation such as accelerated image processing to enhance image clarity, reduce scan time, and improve early detection accuracy in breast cancer screening. Accelerated image processing refers to the use of high-performance computing, such as GPUs or specialized hardware, to rapidly process and enhance digital images while enabling faster reconstruction, analysis, and visualization of complex imaging data and improving efficiency and accuracy in medical imaging. For instance, in June 2025, QT Imaging, Inc., a U.S.-based medical device company, launched its next-generation breast imaging reconstruction software powered by NVIDIA L40 GPU acceleration, delivering faster and more precise image processing, enhanced diagnostic accuracy, and improved workflow efficiency for clinicians, marking a significant advancement in breast imaging technology. This launch aims to streamline breast cancer screening by enabling quicker, more accurate detection, reducing the burden on radiologists, and ultimately improving patient outcomes through advanced, high-speed imaging technology.

What Are Latest Mergers And Acquisitions In The Edge-GPU Breast Tomosynthesis Box Market?

In July 2025, RadNet, Inc., a US-based publicly traded company and the leading provider of outpatient diagnostic imaging services, acquired iCAD, Inc. for an undisclosed amount. Through this acquisition, RadNet, Inc., aims to expand its advanced imaging and diagnostic capabilities by integrating iCAD, Inc.’s innovative cancer detection technologies, enhancing early detection, workflow efficiency, and patient outcomes. iCAD, Inc., is a US-based medical technology company that provides the edge-GPU breast tomosynthesis box.

Regional Outlook

North America was the largest region in the edge-GPU breast tomosynthesis box market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Edge-GPU Breast Tomosynthesis Box Market?

The edge-GPU breast tomosynthesis box market consists of revenues earned by entities by providing services such as enhanced image quality services, reduced radiologist workload services, compliance with regulatory standards services, real-time image reconstruction services, and mobile and point-of-care deployment. The market value includes the value of related goods sold by the service provider or included within the service offering. The edge-GPU breast tomosynthesis box market also includes sales of tomosynthesis scanner, imaging detector, networking hardware, storage device, and imaging workstation. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.